Capitalizing on the concept of local immune suppression by inhalation for lung transplant recipients. Issue 1 (10th November 2021)

• Record Type: Journal Article
• Authors: Iacono, Aldo
• Is Part Of: American journal of transplantation. Volume 22:Issue 1(2022)
• Page Start: 9
• Page End: 11
• Publication Date: 2021-11-10
• Subjects: bronchiolitis obliterans (BOS) -- editorial/personal viewpoint -- immunosuppressant ‐ calcineurin inhibitor: cyclosporine A (CsA) -- lung (allograft) function/dysfunction -- lung transplantation/pulmonology -- translational research/science; Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.16874
• Languages: English
• ISSNs: 1600-6135

Abstract

Abstract : A placebo‐controlled randomized‐trial marked by limited enrollment and early trial termination shows that inhaled cyclosporine, when added to systemic immune suppression for lung transplant recipients, was safe and improved early‐in‐trial clinical parameters of bronchiolitis obliterans syndrome. See Kneidinger et al. (page 222 ).